Skip to content

Cylake

Extraordinarily well-funded, founder-pedigreed platform still pre-beta (expected end of 2026) -- funding and leadership credibility are exceptional, but there is no shipped product yet to independently evaluate.

Visit Website ↗ + Add to Compare
45/100Emerging / Unranked

Innovation Matrix Assessment

Innovation Velocity 7/10

Raised $245M via convertible note (2026, total $290M) atop a $45M seed just months after a 2025 founding -- an exceptionally fast and large capital velocity.

Operational Value 2/10

Pre-product: working with design partners toward a beta expected end of 2026 and general availability in 2027; no production deployments yet.

Market Momentum 6/10

Massive convertible-note round from Lightspeed, Picture Capital, and Redpoint reflects strong investor conviction in the founding team ahead of any shipped product.

Category Disruption 5/10

A ground-up, fully agentic platform purpose-built for sovereign/regulated environments is architecturally ambitious, though unproven until launch.

Real-World Efficacy 2/10

No product is generally available yet, so there is no efficacy evidence, independent or otherwise, to evaluate.

Enduring Relevance 5/10

Unified, agentic security operations for regulated and government organizations addresses a real and growing need, contingent on eventual delivery.

Why CISOs Should Care

Cylake is building a unified, agentic AI-native cybersecurity platform consolidating monitoring, analysis, and incident response for government agencies and highly regulated enterprises that cannot rely on public cloud infrastructure.

What Makes It Different

Founded by Palo Alto Networks founder Nir Zuk and SentinelOne co-founder Ehud Shamir, targeting air-gapped/sovereign-grade regulated environments with a from-scratch, fully agentic platform rather than bolting AI onto legacy tools.

The Matrix Verdict

45/100 — EMERGING / UNRANKED

Extraordinarily well-funded, founder-pedigreed platform still pre-beta (expected end of 2026) -- funding and leadership credibility are exceptional, but there is no shipped product yet to independently evaluate.

Editorial Note: Claims vs. Verified Findings

Funding and leadership background verified via SecurityWeek and Yahoo Finance. No product is yet in general availability, so efficacy claims cannot be evaluated.

Sources